Improved renal recovery with postresuscitation n-acetylcysteine treatment in asphyxiated newborn pigs

Shock

Volumn 35, Issue 4, 2011, Pages 428-433

  Lee, Tze Fun ^a   Liu, Jiang Qin ^a   Li, Ying Qian ^a   Nasim, Khalida ^a   Chaba, Todd ^a   Bigam, David L ^a   Cheung, Po Yin ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Asphyxia; Hemodynamics; Kidney; N acetylcysteine; Neonate; Resuscitation

Indexed keywords

ACETYLCYSTEINE; CASPASE 3; CREATININE; LIPID HYDROPEROXIDE; N ACETYL BETA GLUCOSAMINIDASE; OXYGEN; SODIUM CHLORIDE; ACETYLGLUCOSAMINIDASE;

ACIDOTIC SHOCK; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; CARDIOGENIC SHOCK; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; HEMODYNAMICS; HYPOXIA; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; NEWBORN; NEWBORN HYPOXIA; NONHUMAN; REOXYGENATION; RESUSCITATION; SHAM PROCEDURE; SHOCK; ANIMAL; ASPHYXIA; DRUG EFFECT; KIDNEY; MALE; METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; SWINE; URINE; VASCULARIZATION;

ACETYLCYSTEINE; ACETYLGLUCOSAMINIDASE; ANIMALS; ANIMALS, NEWBORN; ASPHYXIA; HEMODYNAMICS; KIDNEY; MALE; OXIDATIVE STRESS; SWINE;

EID: 79961040984     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181fffec2     Document Type: Article

References (34)

1. Andreoli SP: Acute renal failure in the newborn. Semin Perinatol 28:112-123, 2004.
2. Agras PI, Tarcan A, Baskin E, Cengiz N, Gürakan B, Saatci U: Acute renal failure in the neonatal period. Ren Fail 26:305-309, 2004.
3. Hentschel R, Lödige B, Bulla M: Renal insufficiency in the neonatal period. Clin Nephrol 46:54-58, 1996.
4. Nouri S, Mahdhaoui N, Beizig S, Zakhama R, Salem N, Ben Dhafer S, Methlouthi J, Seboui H: Acute renal failure in full term neonates with perinatal asphyxia. Prospective study of 87 cases. Arch Pediatr 15:229-235, 2008.
5. Haycock GB: Management of acute and chronic renal failure in the newborn. Semin Neonatol 8:325-334, 2003.
6. Abid MR, Razzaque MS, Taguchi T: Oxidant stress in renal pathophysiology. Contrib Nephrol 148:135-153, 2005.
7. Versteilen AM, Di Maggio F, Leemreis JR, Groeneveld AB, Musters RJ, Sipkema P: Molecular mechanisms of acute renal failure following ischemia/reperfusion. Int J Artif Organs 27:1019-1029, 2004.
8. Chatterjee PK: Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review. Naunyn Schmiedebergs Arch Pharmacol 376:1-43, 2007.
9. Birck R, Krzossok S, Markowetz F, Schnulle P, van der Woude FJ, Braun C: Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 362:598-603, 2003.
10. Nitescu N, Ricksten SE, Marcussen N, Haraldsson B, Nilsson U, Basu S, Guron G: N-acetylcysteine attenuates kidney injury in rats subjected to renal ischaemia-reperfusion. Nephrol Dial Transplant 21:1240-1247, 2006.
11. Shimizu MH, Danilovic A, Andrade L, Volpini RA, Libório AB, Sanches TR, Seguro AC: N-acetylcysteine protects against renal injury following bilateral ureteral obstruction. Nephrol Dial Transplant 23:3067-3073, 2008.
12. Johnson ST, Bigam DL, Emara M, Obaid L, Slack G, Korbutt G, Jewell LD, Van Aerde J, Cheung PY: N-acetylcysteine improves the hemodynamics and oxidative stress in hypoxic newborn pigs reoxygenated with 100% oxygen. Shock 28:484-490, 2007.
13. Lee TF, Jantzie LL, Todd KG, Cheung PY: Postresuscitation N-acetylcysteine treatment reduces cerebral hydrogen peroxide in the hypoxic piglet brain. Intensive Care Med 34:190-197, 2008.
14. Gobe G, Willgoss D, Hogg N, Schoch E, Endre Z: Cell survival or death in renal tubular epithelium after ischemia-reperfusion injury. Kidney Int 56: 1299-1304, 1999.
15. Suzuki K: Anti-oxidants for therapeutic use: why are only a few drugs in clinical use? Adv Drug Deliv Rev 61:287-289, 2009.
16. Perlman JM: Systemic abnormalities in term infants following perinatal asphyxia: relevance to long-term neurologic outcome. Clin Perinatol 16:475-484, 1989.
17. Akinbi H, Abbasi S, Hilpert PL, Bhutani VK: Gastrointestinal and renal blood flow velocity profile in neonates with birth asphyxia. J Pediatr 125:625-627, 1994.
18. Luciano R, Gallini F, Romagnoli C, Papacci P, Tortorolo G: Doppler evaluation of renal blood flow velocity as a predictive index of acute renal failure in perinatal asphyxia. Eur J Pediatr 157:656-660, 1998.
19. Efrati S, Berman S, Ilgiyeav I, Siman-Tov Y, Averbukh Z, Weissgarten J: Differential effects of N-acetylcysteine, theophylline or biocarbonate on contrast-induced rat renal vasoconstriction. Am J Nephrol 29:181-191, 2009.
20. Conesa EL, Valero F, Nadal JC, Fenoy FJ, Lopez B, Arregui B, Salom MG: N-acetyl-L-cysteine improves renal medullary hypoperfusion in acute renal failure. Am J Physiol Regul Integr Comp Physiol 281:R730-R737, 2001.
21. Han WQ, Zhu DL, Wu LY, Chen QZ, Guo SJ, Gao PJ: N-acetylcysteine-induced vasodilation involves voltage-gated potassium channels in rat aorta. Life Sci 84:732-737, 2009.
22. Alwaidh MH, Cooke RW, Judd BA: Renal blood flow velocity in acute renal failure following cardiopulmonary bypass surgery. Acta Pediatr 87:644-649, 1998.
23. Skalova S: The diagnostic role of urinary N-acetyl-β-D- glucosaminidase (NAG) activity in the detection of renal tubular impairment. Acta Medica 48:75-80, 2005.
24. Bagshaw SM, Gibney RT: Conventional markers of kidney function. Crit Care Med 36(Suppl 4):S152-S158, 2008.
25. Bonventre JV: Diagnosis of acute kidney injury: from classic parameters to new biomarkers. Contrib Nephrol 156:213-219, 2007.
26. Uz E, Karatas OF, Mete E, Bayrak R, Bayrak O, Atmaca AF, Atis O, Yildirim ME, Akcay A: The effect of dietary ginger (Zingiber officinale Rosc) on renal ischemia/reperfusion injury in rat kidneys. Ren Fail 31:251-260, 2009.
27. Brunet J, Boily MJ, Cordeau S, Des Rosiers C: Effects of N-acetylcysteine in the rat heart reperfused after low-flow ischemia: evidence for a direct scavenging of hydroxyl radicals and a nitric oxide-dependent increase in coronary flow. Free Radic Biol Med 19:627-638, 1995.
28. Zafarullah M, Li WQ, Sylvester J, Ahmad M: Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci 60:6-20, 2003.
29. Kumar S: Caspases and their many biological functions. Cell Death Differ 14:1-2, 2007.
30. Choi DE, Jeong JY, Lim BJ, Chung S, Chang YK, Lee SJ, Na KR, Kim SY, Shin YT, Lee KW: Pretreatment of sildenafil attenuates ischemia-reperfusion renal injury in rats. Am J Physiol Renal Physiol 297:F362-F370, 2009.
31. Kunduzova OR, Escourrou G, Seguelas MH, Delagrange P, De La Farge F, Cambon C, Parini A: Prevention of apoptotic and necrotic cell death, caspase-3 activation, and renal dysfunction by melatonin after ischemia/reperfusion. FASEB J 17:872-874, 2003.
32. Luo J, Tsuji T, Yasuda H, Sun Y, Fujigaki Y, Hishida A: The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats. Nephrol Dial Transplant 23:2198-2205, 2008.
33. Yano T, Itoh Y, Matsuo M, Kawashiri T, Egashira N, Oishi R: Involvement of both tumor necrosis factor-alpha-induced necrosis and p53-mediated caspase-dependent apoptosis in nephrotoxicity of cisplatin. Apoptosis 12:1901-1909, 2007.
34. Chapados I, Cheung PY: Not all models are created equal: animal models to study hypoxic-ischemic encephalopathy of the newborn. Neonatology 94: 293-299, 2008.